FDA approves Pfenex’s osteoporosis therapyAnalysts, Approvals, Bone Building, FDA, FDA/Regulatory, Fractures, Injectables, Market exclusivity, OsteoporosisThe U.S. FDA approved a bone-building drug from Pfenex Inc. to treat osteoporosis in certain patients at high risk for fractures, marking the company’s first commercial product. Read more October 7, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-10-07 06:15:162019-10-07 13:47:29FDA approves Pfenex’s osteoporosis therapy
